These Analysts Revise Their Forecasts On Fifth Third Bancorp After Q3 Results

Fifth Third Bancorp (NASDAQ: FITB) reported better-than-expected earnings for its third quarter.

Fifth Third Bancorp (NASDAQ:FITB) reported better-than-expected earnings for its third quarter.

The company reported third-quarter 2023 sales of $2.16 billion, beating the consensus of $2.15 billion. The adjusted EPS came in at 92 cents, beating the analyst consensus of 82 cents.

The company reported an interest income increase of 44% Y/Y to $2.54 billion, with a net interest income (NII) of $1.45 billion (down 4% Y/Y).

Fifth Third Bancorp shares fell 5.5% to trade at $23.55 on Friday.

These analysts made changes to their price targets on Fifth Third Bancorp following earnings announcement.

  • Morgan Stanley raised the price target on Fifth Third Bancorp from $28 to $29. Morgan Stanley analyst Manan Gosalia maintained an Equal-Weight rating.
  • RBC Capital cut the price target on Fifth Third Bancorp from $34 to $30. RBC Capital analyst Gerard Cassidy maintained an Outperform rating on the stock.

Check This Out: Over $8M Bet On Howard Hughes? Check Out These 3 Stocks Insiders Are Buying

Total
0
Shares
Related Posts
Read More

Earnings Preview For Champions Oncology

Champions Oncology (NASDAQ:CSBR) is set to give its latest quarterly earnings report on Thursday, 2022-09-08. Here's what investors need to know before the announcement. Analysts estimate that Champions Oncology will report an earnings per share (EPS) of $0.01.

CSBR